Chemistry:TCB-2

From HandWiki
Short description: Potent hallucinogenic drug discovered in 2006
TCB-2
TCB-2.png
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In General Unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC11H14BrNO2
Molar mass272.142 g·mol−1
3D model (JSmol)
  (verify)

TCB-2 is a hallucinogen discovered in 2006 by Thomas McLean working in the lab of David Nichols at Purdue University.[1] It is a conformationally-restricted derivative of the phenethylamine 2C-B, also a hallucinogen, and acts as a potent agonist for the 5-HT2A and 5-HT2C receptors with a Ki of 0.26 nM at the human 5-HT2A receptor. In drug-substitution experiments in rats, TCB-2 was found to be of similar potency to both LSD and Bromo-DragonFLY, ranking it among the most potent phenethylamine hallucinogens yet discovered.[1] This high potency and selectivity has made TCB-2 useful for distinguishing 5-HT2A mediated responses from those produced by other similar receptors.[2] TCB-2 has similar but not identical effects in animals to related phenethylamine hallucinogens such as DOI, and has been used for studying how the function of the 5-HT2A receptor differs from that of other serotonin receptors in a number of animal models, such as studies of cocaine addiction and neuropathic pain.[3][4][5][6]

See also

References

  1. 1.0 1.1 "1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists". Journal of Medicinal Chemistry 49 (19): 5794–803. September 2006. doi:10.1021/jm060656o. PMID 16970404. 
  2. "Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation". Neuropharmacology 56 Suppl 1: 213–25. 2009. doi:10.1016/j.neuropharm.2008.07.049. PMID 18762202. 
  3. "The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis". Psychopharmacology 212 (1): 13–23. September 2010. doi:10.1007/s00213-009-1694-1. PMID 19823806. 
  4. "Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury". Neuroscience 168 (3): 831–41. July 2010. doi:10.1016/j.neuroscience.2010.04.032. PMID 20412834. 
  5. "Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine". Psychopharmacology 213 (2–3): 337–54. February 2011. doi:10.1007/s00213-010-1887-7. PMID 20577718. 
  6. "Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice". Neuropharmacology 64: 403–13. January 2013. doi:10.1016/j.neuropharm.2012.06.007. PMID 22722027.